JG
NEO icon

Jefferies Group’s NeoGenomics NEO Stock Holding History

Jefferies Group’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-90,100
Closed -$3.07M – 1821
2021
Q4 		$3.07M Buy
+90,100
New +$3.53M 0.02% 632
2019
Q2 		– Sell
-159,300
Closed -$3.26M – 2759
2019
Q1 		$3.26M Hold
159,300
– – 0.03% 639
2018
Q4 		$2.01M Buy
+159,300
New +$2.37M 0.02% 824

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Jefferies Group's NEO Position: Q1 2022 in Review

Jefferies Group sold out of NeoGenomics (NEO) in Q1 2022, closing a stake of 83,000 shares — an estimated $2.83M sold.

Jefferies Group first reported a position in NEO in Q3 2017 and held it in 5 quarters. The position peaked at $2.83M in Q4 2021. 279 funds tracked by Wall St. Rank hold NEO as of Q1 2022.

  • Jefferies Group reported no remaining NeoGenomics position as of Q1 2022 after selling out during the quarter.
  • Jefferies Group sold 83,000 NeoGenomics shares in Q1 2022, an estimated $2.83M.
  • Jefferies Group first reported a position in NeoGenomics in Q3 2017 and held it in 5 quarters.
  • Jefferies Group's NeoGenomics position peaked at $2.83M in Q4 2021.
  • 279 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2022.

Based on Jefferies Group's 13F filing for Q1 2022, filed 16 May 2022.